After Indian spices, now problems are increasing for the pharmaceutical sector of the country too. Leading Indian pharmaceutical companies like Dr. Reddy’s Laboratories, Sun Pharma and Aurobindo Pharma are withdrawing their various medicines from the American market. Flaws have been found in their manufacturing.
The US Food and Drug Administration (FDA) has classified these recalls as Class-1 and Class-2. It has raised serious concerns about the quality and safety of generic medicines imported from India.
Generic medicines means making another medicine based on the formula of a branded medicine, which is much cheaper. India is the largest manufacturer and exporter of generic medicines. Dr. Reddy’s Laboratories is recalling around 20,000 boxes of Zyvigator. It is used to treat hyperphenylalaninemia in patients with phenylketonuria. Sun Pharma, the country’s largest generic drugmaker, is recalling over 11,000 vials of amphotericin B liposome.
This injection treats antifungals. But the American drug regulator found in its investigation that the quality of Sun Pharma’s injections was not good. Aurobindo Pharma is recalling over 13,000 bottles of Clorazepate Dipotassium tablets. It is an anti-anxiety medicine, that is, it is used to reduce stress.
There were dotted yellow spots on these tablets of Aurobindo Pharma, due to which he had to order the medicine. FDC Ltd is recalling more than 3,80,000 units of Timolol Maleate Ophthalmic Solution, an eye-drop used in the treatment of glaucoma, due to faulty packaging.
Glaucoma is an eye problem. Due to high pressure in the eyes of the patient, the nerve connecting the eye to the brain gets damaged.
